Economic Evaluation of a Medicines Management Model in New Zealand: A Proposal

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter narrates a proposal focusing on building a cost effectiveness medicines management model in community pharmacy. Community pharmacy is taking a central role in medicines management, with an emergent evidence base supporting the importance of these services in improving patient adherence. However, just because a program or service has been shown to demonstrate positive outcomes for patients in a trial setting, it does not mean it will be easily implemented in practice. Economic evaluation plays a central role in this context and can provide an evidence base for funders, policy decision makers and for government authorities. In this context, this proposal will outline the cost-effectiveness of alternative models of medicines management in New Zealand setting. Building a relevant, evidence-based model of care through which greater collaboration is sought within primary care can promote better use of prescribed medicines and can improve patient health outcomes. Though this model is presented in New Zealand setting, however, other high-income countries with the similar health system can adopt a similar approach.

LanguageEnglish
Title of host publicationEconomic Evaluation of Pharmacy Services
PublisherElsevier Inc.
Pages215-221
Number of pages7
ISBN (Electronic)9780128037003
ISBN (Print)9780128036594
DOIs
Publication statusPublished - 14 Oct 2016
Externally publishedYes

Fingerprint

Medicine
Economic evaluation
Management model
New Zealand
Community pharmacy
Cost-effectiveness
Authority
Evidence-based
Income
Decision maker
Primary care
Government
Health outcomes
Alternative models
Adherence

Cite this

Babar, Z-U-D., & Edlin, R. (2016). Economic Evaluation of a Medicines Management Model in New Zealand: A Proposal. In Economic Evaluation of Pharmacy Services (pp. 215-221). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-803659-4.00010-2
Babar, Zaheer-Ud-Din ; Edlin, R. / Economic Evaluation of a Medicines Management Model in New Zealand : A Proposal. Economic Evaluation of Pharmacy Services. Elsevier Inc., 2016. pp. 215-221
@inbook{6dd0022f2eb64fc6bd75e7de4b5d59c7,
title = "Economic Evaluation of a Medicines Management Model in New Zealand: A Proposal",
abstract = "This chapter narrates a proposal focusing on building a cost effectiveness medicines management model in community pharmacy. Community pharmacy is taking a central role in medicines management, with an emergent evidence base supporting the importance of these services in improving patient adherence. However, just because a program or service has been shown to demonstrate positive outcomes for patients in a trial setting, it does not mean it will be easily implemented in practice. Economic evaluation plays a central role in this context and can provide an evidence base for funders, policy decision makers and for government authorities. In this context, this proposal will outline the cost-effectiveness of alternative models of medicines management in New Zealand setting. Building a relevant, evidence-based model of care through which greater collaboration is sought within primary care can promote better use of prescribed medicines and can improve patient health outcomes. Though this model is presented in New Zealand setting, however, other high-income countries with the similar health system can adopt a similar approach.",
keywords = "A proposal, Cost effectiveness model, Exemplar model, Medicines management, New Zealand",
author = "Zaheer-Ud-Din Babar and R. Edlin",
year = "2016",
month = "10",
day = "14",
doi = "10.1016/B978-0-12-803659-4.00010-2",
language = "English",
isbn = "9780128036594",
pages = "215--221",
booktitle = "Economic Evaluation of Pharmacy Services",
publisher = "Elsevier Inc.",
address = "United States",

}

Economic Evaluation of a Medicines Management Model in New Zealand : A Proposal. / Babar, Zaheer-Ud-Din; Edlin, R.

Economic Evaluation of Pharmacy Services. Elsevier Inc., 2016. p. 215-221.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Economic Evaluation of a Medicines Management Model in New Zealand

T2 - A Proposal

AU - Babar, Zaheer-Ud-Din

AU - Edlin, R.

PY - 2016/10/14

Y1 - 2016/10/14

N2 - This chapter narrates a proposal focusing on building a cost effectiveness medicines management model in community pharmacy. Community pharmacy is taking a central role in medicines management, with an emergent evidence base supporting the importance of these services in improving patient adherence. However, just because a program or service has been shown to demonstrate positive outcomes for patients in a trial setting, it does not mean it will be easily implemented in practice. Economic evaluation plays a central role in this context and can provide an evidence base for funders, policy decision makers and for government authorities. In this context, this proposal will outline the cost-effectiveness of alternative models of medicines management in New Zealand setting. Building a relevant, evidence-based model of care through which greater collaboration is sought within primary care can promote better use of prescribed medicines and can improve patient health outcomes. Though this model is presented in New Zealand setting, however, other high-income countries with the similar health system can adopt a similar approach.

AB - This chapter narrates a proposal focusing on building a cost effectiveness medicines management model in community pharmacy. Community pharmacy is taking a central role in medicines management, with an emergent evidence base supporting the importance of these services in improving patient adherence. However, just because a program or service has been shown to demonstrate positive outcomes for patients in a trial setting, it does not mean it will be easily implemented in practice. Economic evaluation plays a central role in this context and can provide an evidence base for funders, policy decision makers and for government authorities. In this context, this proposal will outline the cost-effectiveness of alternative models of medicines management in New Zealand setting. Building a relevant, evidence-based model of care through which greater collaboration is sought within primary care can promote better use of prescribed medicines and can improve patient health outcomes. Though this model is presented in New Zealand setting, however, other high-income countries with the similar health system can adopt a similar approach.

KW - A proposal

KW - Cost effectiveness model

KW - Exemplar model

KW - Medicines management

KW - New Zealand

UR - http://www.scopus.com/inward/record.url?scp=85020630065&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-803659-4.00010-2

DO - 10.1016/B978-0-12-803659-4.00010-2

M3 - Chapter

SN - 9780128036594

SP - 215

EP - 221

BT - Economic Evaluation of Pharmacy Services

PB - Elsevier Inc.

ER -